Then, MDSCs circulate in the blood and spleen and eventually home to tumor sites, in which factors such as interleukin (IL-10) and transforming growth factor beta (TGFβ) secreted by MDSCs accelerate tumor growth by impeding antitumor activity and promoting suppressive cell differentiation [8,9]. This evidence concerns the gene TGFB1 and neoplasm.